# All In FutureTech Alliance, Inc.: financial statements, quarterly

AIFA · Nasdaq · CIK 1708341 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aifa.md) · [Financials](/companies/aifa/financials.md) · [Filings](/companies/aifa/filings.md) · [Insiders](/companies/aifa/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aifa/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.1](/filings/0001213900-24-098566.md) | [2.1 d](/filings/0001213900-24-027346.md) | [2.4](/filings/0001213900-24-045259.md) | [2.6](/filings/0001213900-24-070775.md) | [2.2](/filings/0001213900-24-098566.md) | [1.9 d](/filings/0001171843-26-003627.md) | [2.3](/filings/0001213900-26-068870.md) | [1.9](/filings/0001213900-26-090237.md) | [1.8](/filings/0001213900-25-112690.md) | [1.9 d](/filings/0001171843-26-003627.md) | [1.6](/filings/0001213900-26-068870.md) | [1.2](/filings/0001213900-26-090237.md) |
| Research and development | $m | not reported | not reported | [0.2](/filings/0001213900-25-061782.md) | [0.2](/filings/0001213900-25-076748.md) | [0.2](/filings/0001213900-25-112690.md) | [0.3 d](/filings/0001171843-26-003627.md) | [0.2](/filings/0001213900-26-068870.md) | [0.2](/filings/0001213900-26-090237.md) | [0.2](/filings/0001213900-25-112690.md) | [0.2 d](/filings/0001171843-26-003627.md) | [0.2](/filings/0001213900-26-068870.md) | [0.0](/filings/0001213900-26-090237.md) |
| Operating income | $m | [(0.6)](/filings/0001213900-24-098566.md) | [(1.9) d](/filings/0001213900-25-052248.md) | [(2.7)](/filings/0001213900-25-061782.md) | [(5.3)](/filings/0001213900-25-076748.md) | [(1.2)](/filings/0001213900-25-112690.md) | [(14.2) d](/filings/0001171843-26-003627.md) | [(5.3)](/filings/0001213900-26-068870.md) | [(6.1)](/filings/0001213900-26-090237.md) | [(7.3)](/filings/0001213900-25-112690.md) | [(20.4) d](/filings/0001171843-26-003627.md) | [(3.5)](/filings/0001213900-26-068870.md) | [(2.3)](/filings/0001213900-26-090237.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | [(0.3)](/filings/0001213900-25-112690.md) | [(0.1) d](/filings/0001171843-26-003627.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [0.1](/filings/0001213900-24-098566.md) | [(0.9) d](/filings/0001213900-25-052248.md) | [(1.7)](/filings/0001213900-25-061782.md) | [(3.8)](/filings/0001213900-25-076748.md) | [(4.0)](/filings/0001213900-25-112690.md) | [(7.2) d](/filings/0001171843-26-003627.md) | [(4.8)](/filings/0001213900-26-068870.md) | [(4.8)](/filings/0001213900-26-090237.md) | [(5.4)](/filings/0001213900-25-112690.md) | [(17.8) d](/filings/0001171843-26-003627.md) | [(5.2)](/filings/0001213900-26-068870.md) | [(0.6)](/filings/0001213900-26-090237.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001213900-24-098566.md) | not reported | [(0.04)](/filings/0001213900-25-061782.md) | [(0.09)](/filings/0001213900-25-076748.md) | [(0.11)](/filings/0001213900-25-112690.md) | not reported | [(0.67)](/filings/0001213900-26-068870.md) | [(0.73)](/filings/0001213900-26-090237.md) | [(0.14)](/filings/0001213900-25-112690.md) | not reported | [(0.83)](/filings/0001213900-26-068870.md) | [(0.09)](/filings/0001213900-26-090237.md) |
| Basic EPS | $ per share | [0.00](/filings/0001213900-24-098566.md) | not reported | [(0.04)](/filings/0001213900-25-061782.md) | [(0.09)](/filings/0001213900-25-076748.md) | [(0.11)](/filings/0001213900-25-112690.md) | not reported | [(0.67)](/filings/0001213900-26-068870.md) | [(0.73)](/filings/0001213900-26-090237.md) | [(0.14)](/filings/0001213900-25-112690.md) | not reported | [(0.83)](/filings/0001213900-26-068870.md) | [(0.09)](/filings/0001213900-26-090237.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2024 (2024-12-31) | period not labelled (2025-01-31) | period not labelled (2025-03-11) | Q1 FY2025 (2025-03-31) | period not labelled (2025-04-15) | Q2 FY2025 (2025-06-30) | period not labelled (2025-07-23) | Q3 FY2025 (2025-09-30) | period not labelled (2025-10-23) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [59.2](/filings/0001171843-26-003627.md) | not reported | not reported | [19.5](/filings/0001213900-25-061782.md) | not reported | [23.1](/filings/0001213900-25-076748.md) | not reported | [15.4](/filings/0001213900-25-112690.md) | not reported | [11.8](/filings/0001213900-26-090237.md) | [4.3](/filings/0001213900-26-068870.md) | [10.4](/filings/0001213900-26-090237.md) |
| Current assets | $m | [94.7](/filings/0001171843-26-003627.md) | not reported | not reported | [98.0](/filings/0001213900-25-061782.md) | not reported | [87.5](/filings/0001213900-25-076748.md) | not reported | [83.1](/filings/0001213900-25-112690.md) | not reported | [76.8](/filings/0001213900-26-090237.md) | [55.1](/filings/0001213900-26-068870.md) | [52.1](/filings/0001213900-26-090237.md) |
| Total assets | $m | [113](/filings/0001171843-26-003627.md) | not reported | not reported | [118](/filings/0001213900-25-061782.md) | not reported | [109](/filings/0001213900-25-076748.md) | not reported | [107](/filings/0001213900-25-112690.md) | not reported | [89.8](/filings/0001213900-26-090237.md) | [68.1](/filings/0001213900-26-068870.md) | [62.2](/filings/0001213900-26-090237.md) |
| Current liabilities | $m | [30.5](/filings/0001171843-26-003627.md) | not reported | not reported | [40.7](/filings/0001213900-25-061782.md) | not reported | [42.7](/filings/0001213900-25-076748.md) | not reported | [46.4](/filings/0001213900-25-112690.md) | not reported | [49.6](/filings/0001213900-26-090237.md) | [33.1](/filings/0001213900-26-068870.md) | [30.9](/filings/0001213900-26-090237.md) |
| Total liabilities | $m | [35.2](/filings/0001171843-26-003627.md) | not reported | not reported | [45.0](/filings/0001213900-25-061782.md) | not reported | [46.5](/filings/0001213900-25-076748.md) | not reported | [49.9](/filings/0001213900-25-112690.md) | not reported | [52.1](/filings/0001213900-26-090237.md) | [35.2](/filings/0001213900-26-068870.md) | [31.1](/filings/0001213900-26-090237.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | [6.2](/filings/0001213900-26-090237.md) | [2.3](/filings/0001213900-26-090237.md) | [10.9](/filings/0001213900-26-090237.md) | [4.7](/filings/0001213900-25-112690.md) | [11.1](/filings/0001213900-26-090237.md) | [4.6](/filings/0001213900-26-090237.md) | [10.8](/filings/0001213900-26-090237.md) | [4.5](/filings/0001213900-26-090237.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [73.0](/filings/0001171843-26-003627.md) | not reported | not reported | [68.4](/filings/0001213900-25-061782.md) | not reported | [57.5](/filings/0001213900-25-076748.md) | not reported | [52.4](/filings/0001213900-25-112690.md) | not reported | [34.8](/filings/0001213900-26-090237.md) | [29.9](/filings/0001213900-26-068870.md) | [29.5](/filings/0001213900-26-090237.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,588) d](/filings/0001213900-24-098566.md) | [(3,540) d](/filings/0001213900-25-052248.md) | [(2,145)](/filings/0001213900-25-061782.md) | [(2,394) d](/filings/0001213900-25-076748.md) | [(8,710) d](/filings/0001213900-25-112690.md) | [3,480 d](/filings/0001171843-26-003627.md) | [(2,184)](/filings/0001213900-26-068870.md) | [(890) d](/filings/0001213900-26-090237.md) | [(616) d](/filings/0001213900-25-112690.md) | [(6,095) d](/filings/0001171843-26-003627.md) | [(661)](/filings/0001213900-26-068870.md) | [(2,356) d](/filings/0001213900-26-090237.md) |
| Capital expenditure | $k | [37.7 d](/filings/0001213900-24-098566.md) | [259 d](/filings/0001213900-25-052248.md) | [10.6](/filings/0001213900-25-061782.md) | [2.8 d](/filings/0001213900-25-076748.md) | [35.1 d](/filings/0001213900-25-112690.md) | [34.4 d](/filings/0001171843-26-003627.md) | [32.3](/filings/0001213900-26-068870.md) | [23.3 d](/filings/0001213900-26-090237.md) | [53.3 d](/filings/0001213900-25-112690.md) | [9.6 d](/filings/0001171843-26-003627.md) | not reported | not reported |
| Share repurchases | $k | [177 d](/filings/0001213900-24-098566.md) | [32.0 d](/filings/0001213900-25-052248.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [39.1](/filings/0001213900-23-085341.md) | [37.9](/filings/0001213900-24-045259.md) | [37.2](/filings/0001213900-24-070775.md) | [37.1](/filings/0001213900-24-098566.md) | [38.9](/filings/0001213900-25-061782.md) | [43.2](/filings/0001213900-25-076748.md) | [37.2](/filings/0001213900-25-112690.md) | [7.3](/filings/0001213900-26-068870.md) | [6.6](/filings/0001213900-26-090237.md) | [38.2](/filings/0001213900-25-112690.md) | [6.2](/filings/0001213900-26-068870.md) | [6.2](/filings/0001213900-26-090237.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,420,316 at 2026-08-04, from the cover of the [10-Q filed 2026-08-14](/filings/0001213900-26-090237.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.